These authors contributed equally to this work.
Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression
Article first published online: 6 FEB 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 59, Issue 3, pages 958–973, March 2014
How to Cite
Xia, L., Huang, W., Tian, D., Zhang, L., Qi, X., Chen, Z., Shang, X., Nie, Y. and Wu, K. (2014), Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression. Hepatology, 59: 958–973. doi: 10.1002/hep.26735
Potential conflict of interest: Nothing to report.
Supported by combined grants from the National Natural Science Foundation of China (No. 81272652, No. 81172290, No. 91129723, No. 81090270, and No. 81090273), the National Key and Basic Research Development Program of China (No. 2010CB529302 and 2010CB529306), the National Municipal Science and Technology Project (2009ZX09103-667 and 2009ZX09301-009-RC06), and the Chinese Postdoctoral Science Foundation (No. 20100471776 and No. 201104757).
- Issue published online: 25 FEB 2014
- Article first published online: 6 FEB 2014
- Accepted manuscript online: 5 SEP 2013 06:28AM EST
- Manuscript Accepted: 30 AUG 2013
- Manuscript Revised: 29 AUG 2013
- Manuscript Received: 12 JUN 2013
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.